Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antiarrhythmic Effects of Melatonin and Omega-3 Are Linked with Protection of Myocardial Cx43 Topology and Suppression of Fibrosis in Catecholamine Stressed Normotensive and Hypertensive Rats

B. Szeiffova Bacova, C. Viczenczova, K. Andelova, M. Sykora, K. Chaudagar, M. Barancik, M. Adamcova, V. Knezl, T. Egan Benova, P. Weismann, J. Slezak, N. Tribulova,

. 2020 ; 9 (6) : . [pub] 20200622

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20019022

Grantová podpora
2/0002/20, 2/0158/19 Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
18-0548, 15-0376, 15-0119 Agentúra na Podporu Výskumu a Vývoja
Q 40/5 Programme Progres
26230120009 EU ITMS

Cardiac β-adrenergic overstimulation results in oxidative stress, hypertrophy, ischemia, lesion, and fibrosis rendering the heart vulnerable to malignant arrhythmias. We aimed to explore the anti-arrhythmic efficacy of the anti-oxidative and anti-inflammatory compounds, melatonin, and omega-3, and their mechanisms of actions in normotensive and hypertensive rats exposed to isoproterenol (ISO) induced β-adrenergic overdrive. Eight-month-old, male SHR, and Wistar rats were injected during 7 days with ISO (cumulative dose, 118 mg/kg). ISO rats were either untreated or concomitantly treated with melatonin (10 mg/kg/day) or omega-3 (Omacor, 1.68 g/kg/day) until 60 days of ISO withdrawal and compared to non-ISO controls. Findings showed that both melatonin and omega-3 increased threshold current to induce ventricular fibrillation (VF) in ISO rats regardless of the strain. Prolonged treatment with these compounds resulted in significant suppression of ISO-induced extracellular matrix alterations, as indicated by reduced areas of diffuse fibrosis and decline of hydroxyproline, collagen-1, SMAD2/3, and TGF-β1 protein levels. Importantly, the highly pro-arrhythmic ISO-induced disordered cardiomyocyte distribution of electrical coupling protein, connexin-43 (Cx43), and its remodeling (lateralization) were significantly attenuated by melatonin and omega-3 in Wistar as well as SHR hearts. In parallel, both compounds prevented the post-ISO-related increase in Cx43 variant phosphorylated at serine 368 along with PKCε, which are known to modulate Cx43 remodeling. Melatonin and omega-3 increased SOD1 or SOD2 protein levels in ISO-exposed rats of both strains. Altogether, the results indicate that anti-arrhythmic effects of melatonin and omega-3 might be attributed to the protection of myocardial Cx43 topology and suppression of fibrosis in the setting of oxidative stress induced by catecholamine overdrive in normotensive and hypertensive rats.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20019022
003      
CZ-PrNML
005      
20201123124613.0
007      
ta
008      
201103s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antiox9060546 $2 doi
035    __
$a (PubMed)32580481
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Szeiffova Bacova, Barbara $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
245    10
$a Antiarrhythmic Effects of Melatonin and Omega-3 Are Linked with Protection of Myocardial Cx43 Topology and Suppression of Fibrosis in Catecholamine Stressed Normotensive and Hypertensive Rats / $c B. Szeiffova Bacova, C. Viczenczova, K. Andelova, M. Sykora, K. Chaudagar, M. Barancik, M. Adamcova, V. Knezl, T. Egan Benova, P. Weismann, J. Slezak, N. Tribulova,
520    9_
$a Cardiac β-adrenergic overstimulation results in oxidative stress, hypertrophy, ischemia, lesion, and fibrosis rendering the heart vulnerable to malignant arrhythmias. We aimed to explore the anti-arrhythmic efficacy of the anti-oxidative and anti-inflammatory compounds, melatonin, and omega-3, and their mechanisms of actions in normotensive and hypertensive rats exposed to isoproterenol (ISO) induced β-adrenergic overdrive. Eight-month-old, male SHR, and Wistar rats were injected during 7 days with ISO (cumulative dose, 118 mg/kg). ISO rats were either untreated or concomitantly treated with melatonin (10 mg/kg/day) or omega-3 (Omacor, 1.68 g/kg/day) until 60 days of ISO withdrawal and compared to non-ISO controls. Findings showed that both melatonin and omega-3 increased threshold current to induce ventricular fibrillation (VF) in ISO rats regardless of the strain. Prolonged treatment with these compounds resulted in significant suppression of ISO-induced extracellular matrix alterations, as indicated by reduced areas of diffuse fibrosis and decline of hydroxyproline, collagen-1, SMAD2/3, and TGF-β1 protein levels. Importantly, the highly pro-arrhythmic ISO-induced disordered cardiomyocyte distribution of electrical coupling protein, connexin-43 (Cx43), and its remodeling (lateralization) were significantly attenuated by melatonin and omega-3 in Wistar as well as SHR hearts. In parallel, both compounds prevented the post-ISO-related increase in Cx43 variant phosphorylated at serine 368 along with PKCε, which are known to modulate Cx43 remodeling. Melatonin and omega-3 increased SOD1 or SOD2 protein levels in ISO-exposed rats of both strains. Altogether, the results indicate that anti-arrhythmic effects of melatonin and omega-3 might be attributed to the protection of myocardial Cx43 topology and suppression of fibrosis in the setting of oxidative stress induced by catecholamine overdrive in normotensive and hypertensive rats.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Viczenczova, Csilla $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia. Research Center for Molecular Medicine of the Austrian Academy of Sciences, A-1090 Vienna, Austria.
700    1_
$a Andelova, Katarina $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Sykora, Matus $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Chaudagar, Kiranj $u L. M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
700    1_
$a Barancik, Miroslav $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Adamcova, Michaela $u Department of Physiology, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic.
700    1_
$a Knezl, Vladimir $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Egan Benova, Tamara $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Weismann, Peter $u Faculty of Medicine, Comenius University, 81499 Bratislava, Slovakia.
700    1_
$a Slezak, Jan $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
700    1_
$a Tribulova, Narcisa $u Centre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
773    0_
$w MED00200130 $t Antioxidants (Basel, Switzerland) $x 2076-3921 $g Roč. 9, č. 6 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32580481 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201103 $b ABA008
991    __
$a 20201123124612 $b ABA008
999    __
$a ind $b bmc $g 1585802 $s 1109220
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 6 $e 20200622 $i 2076-3921 $m Antioxidants $n Antioxidants $x MED00200130
GRA    __
$a 2/0002/20, 2/0158/19 $p Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
GRA    __
$a 18-0548, 15-0376, 15-0119 $p Agentúra na Podporu Výskumu a Vývoja
GRA    __
$a Q 40/5 $p Programme Progres
GRA    __
$a 26230120009 $p EU ITMS
LZP    __
$a Pubmed-20201103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace